132 related articles for article (PubMed ID: 8253556)
21. Simple predictors of survival in head and neck squamous cell carcinoma.
Medow MA; Weed HG; Schuller DE
Arch Otolaryngol Head Neck Surg; 2002 Nov; 128(11):1282-6. PubMed ID: 12431171
[TBL] [Abstract][Full Text] [Related]
22. A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group Study.
Poulsen MG; Denham JW; Peters LJ; Lamb DS; Spry NA; Hindley A; Krawitz H; Hamilton C; Keller J; Tripcony L; Walker Q
Radiother Oncol; 2001 Aug; 60(2):113-22. PubMed ID: 11439206
[TBL] [Abstract][Full Text] [Related]
23. Radical radiotherapy in head and neck squamous cell carcinoma: an analysis of prognostic and therapeutic factors.
Dinshaw KA; Agarwal JP; Ghosh-Laskar S; Gupta T; Shrivastava SK
Clin Oncol (R Coll Radiol); 2006 Jun; 18(5):383-9. PubMed ID: 16817329
[TBL] [Abstract][Full Text] [Related]
24. Using the TNM system to predict survival in squamous cell carcinoma of the head and neck.
Hall SF; Groome PA; Rothwell D; Dixon PF
Anticancer Res; 1998; 18(6B):4777-8. PubMed ID: 9891556
[TBL] [Abstract][Full Text] [Related]
25. The expression of activin receptor-like kinase 1 among patients with head and neck cancer.
Chien CY; Chuang HC; Chen CH; Fang FM; Chen WC; Huang CC; Huang HY
Otolaryngol Head Neck Surg; 2013 Jun; 148(6):965-73. PubMed ID: 23447486
[TBL] [Abstract][Full Text] [Related]
26. Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy.
Chan AK; Wong A; Jenken D; Heine J; Buie D; Johnson D
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):665-77. PubMed ID: 15708244
[TBL] [Abstract][Full Text] [Related]
27. Potential doubling time in head and neck tumors treated by primary radiotherapy: preliminary evidence for a prognostic significance in local control.
Corvò R; Giaretti W; Sanguineti G; Geido E; Orecchia R; Barra S; Margarino G; Bacigalupo A; Vitale V
Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1165-72. PubMed ID: 8262843
[TBL] [Abstract][Full Text] [Related]
28. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
[TBL] [Abstract][Full Text] [Related]
29. Overview of the 8th Edition TNM Classification for Head and Neck Cancer.
Huang SH; O'Sullivan B
Curr Treat Options Oncol; 2017 Jul; 18(7):40. PubMed ID: 28555375
[TBL] [Abstract][Full Text] [Related]
30. Nonnasopharyngeal lymphoepithelioma of the head and neck.
Dubey P; Ha CS; Ang KK; El-Naggar AK; Knapp C; Byers RM; Morrison WH
Cancer; 1998 Apr; 82(8):1556-62. PubMed ID: 9554534
[TBL] [Abstract][Full Text] [Related]
31. Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27.
Lee WR; Berkey B; Marcial V; Fu KK; Cooper JS; Vikram B; Coia LR; Rotman M; Ortiz H
Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1069-75. PubMed ID: 9869231
[TBL] [Abstract][Full Text] [Related]
32. Pros and Cons of the New Edition of TNM Classification of Head and Neck Squamous Cell Carcinoma.
Denaro N; Russi EG; Merlano MC
Oncology; 2018; 95(4):202-210. PubMed ID: 29975952
[TBL] [Abstract][Full Text] [Related]
33. Usefulness of tumor volumetry as a prognostic factor of survival in head and neck cancer.
Kurek R; Kalogera-Fountzila A; Muskalla K; Dafni U; Schnabel T; Kober B; Röddiger S; Martin T; Fountzilas G; Zamboglou N
Strahlenther Onkol; 2003 May; 179(5):292-7. PubMed ID: 12740655
[TBL] [Abstract][Full Text] [Related]
34. Using TNM staging to predict survival in patients with squamous cell carcinoma of head & neck.
Hall SF; Groome PA; Rothwell D; Dixon PF
Head Neck; 1999 Jan; 21(1):30-8. PubMed ID: 9890348
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the newly updated TNM classification of head and neck carcinoma with data from 3247 patients.
Iro H; Waldfahrer F
Cancer; 1998 Nov; 83(10):2201-7. PubMed ID: 9827726
[TBL] [Abstract][Full Text] [Related]
36. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
37. Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma.
Xing Y; Zhang J; Lin H; Gold KA; Sturgis EM; Garden AS; Lee JJ; William WN
Cancer; 2016 Feb; 122(4):534-45. PubMed ID: 26554754
[TBL] [Abstract][Full Text] [Related]
38. Toxic cure: Hyperfractionated radiotherapy with concurrent cisplatin and fluorouracil for Stage III and IVA head-and-neck cancer in the community.
Maguire PD; Meyerson MB; Neal CR; Hamann MS; Bost AL; Anagnost JW; Ungaro PC; Pollock HD; McMurray JE; Wilson EP; Kotwall CA
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):698-704. PubMed ID: 14967423
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
[TBL] [Abstract][Full Text] [Related]
40. Tumor angiogenesis and prognosis in squamous cell carcinoma of the head and neck.
Zätterström UK; Brun E; Willén R; Kjellén E; Wennerberg J
Head Neck; 1995; 17(4):312-8. PubMed ID: 7545656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
